Table 3.

Five-year survival rates with surgery and without surgery treatment in localised and advanced stage

		With surgery treatment(S, SCT and SCRT)(n = 41), 5-year survival (%)	Without surgery treatment(CT and CRT)(n = 102), 5-year survival (%)	p value
Stage I–II	EFS	(n = 37), 64%	(n = 69), 54%	0.519
Stage IV	EFS	(n = 4), 66%	(n = 33), 46%
Stage I–II	OS	(n = 37), 78%	(n = 69), 62%
Stage IV	OS	(n = 4), 66%	(n = 33), 41%	0.165

CT – chemotherapy; RT – radiotherapy; S – surgery; SCT – surgery and chemotherapy; SCRT – surgery along with chemotherapy and radiotherapy